Predict your next investment

INTERNET | Internet Software & Services / Healthcare

See what CB Insights has to offer

Founded Year



Acq - Pending | Acquired

Total Raised




About Science 37

Science 37 orchestrates digital clinical trials. Researchers can use the platform for end-to-end trial management and as a window into a study’s progression—it provides centralized data management with actionable insights available in real time. The platform integrates workflow and processes for physician investigators, mobile nurses, and coordinators across the patient journey, and also digitally automates and streamlines all aspects of data collection.

Science 37 Headquarter Location

12121 Bluff Creek Drive Suite 100

Los Angeles, California, 90094,

United States


Latest Science 37 News

Science 37 Plans to Double Workforce

Oct 20, 2021

Science 37 has conducted over 100 virtual clinical trials since 2014. Culver City-based Science 37 Inc., which completed its merger to go public through New York City-based blank check firm LifeSci Acquisition II Corp. earlier this month, recently began trading. Now, the medical research and technology company is already laying out ambitious plans for growth. Science 37 enables virtual participation in clinical trials. The service has been a boon to ailing patients, particularly in the midst of a pandemic as workplace and health and safety restrictions have increased. Patients who participate in trials are often too sick to travel to medical facilities that are an average of 26 miles away from their homes, according to Science 37 research. Though Science 37 is seeking growth opportunities, there is one thing it won’t do to lure more investors: issue SPAC warrants. “I think it is important to note here (that) the way we positioned the company is different,” Science 37 Chief Executive David Coman said. “One SPAC we chose is a little different because it’s a warrantless SPAC. It’s a meaningful differentiation for what’s happened out there.” Most SPACs give investors warrants, or a legal obligation to buy or sell stock at a certain price in a company. In the case of Science 37, these warrants were not offered to investors, giving the company a clean balance sheet. Because Science 37 didn’t have warrants, explained Coman, the company’s stock shook off some of these bearish effects when it opened for trading on Oct. 7. The stock, which traded under the symbol of SNCE, closed at $10.05 in its trading debut, up 7.3% from its $9.37 open. Since Science 37 was founded in 2014, the research firm has raised $147.5 million in venture capital funds. It plans to double its employee count to 650 within a year. Coman said that the company is also looking at acquisition opportunities. “The plan put forward is an organic plan,” he said. “So, if there are opportunistic acquisitions, we would look to do some.” Coman said the company has conducted more than 100 virtual clinical trials and engaged several hundreds of thousands of patients. He declined to specify what percentage of those trials is related to Covid-19 but said it is a meaningful figure. For reprint and licensing requests for this article, CLICK HERE . Read Our Newsletter (FREE)

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Science 37

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Science 37 is included in 6 Expert Collections, including Clinical Trials Tech.


Clinical Trials Tech

318 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.


Future of Pharma R&D

62 items


Google In Healthcare

61 items

The healthcare companies and initiatives that Google has invested in or is a part of


Conference Exhibitors

5,302 items


Infectious Disease

2,225 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.


Digital Health 150 (2020)

150 items

The winners of the second annual CB Insights Digital Health 150.

Science 37 Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Science 37 Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.